Environmental
Emissions, effluents and waste
Environmental policy |
|
Environmental management systems (EMS) |
Managerial and board-level responsibility for environmental issues: |
Identification of products, activities and services that have significant impacts on the environment: Health, Safety and Environment Policy | |
Compliance with environmental regulation: Health, Safety and Environment Policy | |
Objectives, targets and deadlines: 2025-2030 environmental targets | |
Environmental programs: | |
Roles and responsibilities: | |
Training and awareness programs for employees: Health, Safety and Environment Policy | |
Internal and external communications on environmental management issues: | |
Monitoring and measurement: | |
Environmental performance records: Novartis Health, Safety and Environment (HSE) Data 2019 | |
External/Internal environmental audits:
|
|
Corrective actions to stimulate continual improvement: Health, Safety and Environment Policy | |
EMS certification | Health, Safety and Environment Policy |
Hazardous waste management | Commitment to reducing hazardous waste |
Air emissions |
Identification of relevant air emissions: Novartis Health, Safety and Environment (HSE) Data 2019 |
Details of initiatives to reduce air emissions:
|
|
Monitoring and measurement: Novartis Health, Safety and Environment (HSE) Data 2019 | |
GHG reduction programs |
Policy commitment to reduce GHG emissions: Climate |
Managerial responsibility for GHG emissions: CDP Climate 2019 (p.6) | |
Initiatives to reduce GHG emissions: | |
GHG reduction targets and deadlines: 2025-2030 environmental targets | |
GHG emissions monitoring and measurement: | |
Regular GHG audits or verification: CDP Climate 2019 | |
Renewable energy programs and use of cleaner energy sources |
Current programs:
|
Targets and deadlines: | |
Green procurement policy and programs to reduce toxic release footprint associated with the supply chain |
Supplier programs (compliance): Novartis in Society 2019 (p.15) |
Supplier programs (beyond compliance): Novartis in Society 2019 (p.43-45) | |
Policy addresses process and product-related requirements: Novartis Third Party Code |
|
Details and extent of supplier environmental screening and audits (p.64) | |
CDP participation |
Greenhouse gas emissions (Scope 1, 2, and 3) |
Data (including historical data): |
Trends: Novartis Health, Safety and Environment (HSE) Data 2019 |
|
Progress against targets (including track record of achieving previous targets): |
|
Intensity: Novartis Health, Safety and Environment (HSE) Data 2019 |
|
3 year average intensity: Novartis Health, Safety and Environment (HSE) Data 2019 |
|
Average annual % change: Novartis Health, Safety and Environment (HSE) Data 2019 |
|
Renewable energy usage |
Data (including historical data): |
Trends: Novartis Health, Safety and Environment (HSE) Data 2019 |
|
Progress against targets (including track record of achieving previous targets): |
|
Average annual % change: Novartis Health, Safety and Environment (HSE) Data 2019 |
|
Waste targets (hazardous, non-hazardous waste) | Data (including historical data): |
Trends: Novartis Health, Safety and Environment (HSE) Data 2019 | |
Progress against targets (including track record of achieving previous targets): | |
Average annual % change: Novartis Health, Safety and Environment (HSE) Data 2019 | |
Air emissions (SOx, NOx, VOC, Ozone depleting substances) | Data (including historical data): |
Trends: Novartis Health, Safety and Environment (HSE) Data 2019 | |
Progress against targets (including track record of achieving previous targets): | |
Average annual % change: Novartis Health, Safety and Environment (HSE) Data 2019 |